home / stock / crtpf / crtpf news

CRTPF News and Press, Cardiol Therapeutics From 06/02/20

Stock Information
Company Name: Cardiol Therapeutics
Stock Symbol: CRTPF
Market: OTC
Menu
CRTPF CRTPF Quote CRTPF Short CRTPF News CRTPF Articles CRTPF Message Board
Get CRTPF Alerts

News, Short Squeeze, Breakout and More Instantly...
CRTPF - Cardiol Therapeutics Reports 2020 AGM Results

Oakville, Ontario--(Newsfile Corp. - June 2, 2020) - Cardiol Therapeutics Inc. ( TSX: CRDL) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, announces ...
CRTPF - CannabisNewsBreaks - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) to Secure $11.25 Million in Bought Deal Public Offering

Cardiol Therapeutics (TSX: CRDL) (OTCQX: CRTPF), a leader in the production of pharmaceutical cannabidiol (“CBD”) and the development of innovative cannabidiol products for heart diseases, recently announced its entry into an agreement with Canaccord Genuity Corp. (the "Lead Unde...

CRTPF - Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT

Oakville, Ontario--(Newsfile Corp. - May 29, 2020) - Cardiol Therapeutics Inc. ( TSX: CRDL)  ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is pl...

CRTPF - Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering

Oakville, Ontario--(Newsfile Corp. - May 14, 2020) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is please...
CRTPF - Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering

Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering Canada NewsWire OAKVILLE, ON, May 13, 2020 /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES NO...

CRTPF - Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19

Oakville, Ontario--(Newsfile Corp. - May 6, 2020) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart diseases, is pleased to...

CRTPF - Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart

Oakville, Ontario--(Newsfile Corp. - April 14, 2020) -  Cardiol Therapeutics Inc.  ( TSX: CRDL) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart disease...
CRTPF - Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure

Oakville, Ontario--(Newsfile Corp. - April 1, 2020) -  Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart disease, is ...

CRTPF - Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A

Oakville, Ontario--(Newsfile Corp. - March 26, 2020) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart disease, today fi...

CRTPF - Cardiol Therapeutics inks deal for pharmaceutical cannabidiol

Cardiol Therapeutics ( OTCPK:CRTPF ) has signed a supplier agreement to offer its pharmaceutically produced cannabidiol to Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart. More news on: Cardiol Therapeutics Inc., Healthcare stocks news, Read more ...

Previous 10 Next 10